Development of metabolic syndrome at a young age as a manifestation of familial partial lipodystrophy type 3 (PPARG mutation): the first description of its clinical case in Russia

Metabolic syndrome (MS) is extremely common (20%–25% of the world’s population), and its diagnostic criteria are defined and well known. It has been shown that patients who have MS are twice as likely to die from a cardiovascular complication and three times as likely to suffer from it compared with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ekaterina Leonidovna Sorkina, Marina Fedorovna Kalashnikova, Natalya Vyacheslavovna Likhodey, Ekaterina Olegova Koksharova, Dmitry Vladimirovich Ustyuzhanin, Alexander Yuryevich Mayorov, Marina Vladimirovna Shestakova, Anatoly Nikolaevich Tiulpakov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2015
Materias:	metabolic syndrome familial partial lipodystrophy type 3 pparg insulin resistance impaired glucose tolerance acanthosis nigricans polycystic ovary syndrome Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/4fbbd980baef4951b83935980887ef05
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Development of metabolic syndrome at a young age as a manifestation of familial partial lipodystrophy type 3 (PPARG mutation): the first description of its clinical case in Russia

Ejemplares similares